A carregar...
Pharmacogenomics, Evidence, and the Role of Payers
Initial enthusiasm for the potential of pharmacogenomics (PGx) to transform medical practice has been tempered by the reality that the process of biomarker discovery, validation, and clinical qualification has been disappointingly slow, with a limited number of PGx tests entering the marketplace sin...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2836944/ https://ncbi.nlm.nih.gov/pubmed/19204417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000189627 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|